Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion

Clinical trial NCT04664725 · UNKNOWN

Trial details

NCT number: NCT04664725
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer Patients

Start date: 2020-06-01
Primary completion: 2021-01-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.